- Home
- GNSS vs ME Comparison
GNSS vs ME Comparison
Compare GNSS & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ME
- Stock Information
- Founded
- GNSS 1992
- ME 2006
- Country
- GNSS United States
- ME United States
- Employees
- GNSS N/A
- ME N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ME Precision Instruments
- Sector
- GNSS Consumer Staples
- ME Health Care
- Exchange
- GNSS Nasdaq
- ME Nasdaq
- Market Cap
- GNSS 116.8M
- ME 98.7M
- IPO Year
- GNSS N/A
- ME N/A
- Fundamental
- Price
- GNSS $2.71
- ME $3.44
- Analyst Decision
- GNSS Strong Buy
- ME Hold
- Analyst Count
- GNSS 3
- ME 1
- Target Price
- GNSS $5.33
- ME $9.40
- AVG Volume (30 Days)
- GNSS 182.0K
- ME 219.4K
- Earning Date
- GNSS 02-11-2025
- ME 02-05-2025
- Dividend Yield
- GNSS N/A
- ME N/A
- EPS Growth
- GNSS N/A
- ME N/A
- EPS
- GNSS N/A
- ME N/A
- Revenue
- GNSS $24,008,000.00
- ME $193,260,000.00
- Revenue This Year
- GNSS $136.42
- ME $21.93
- Revenue Next Year
- GNSS $56.53
- ME $17.31
- P/E Ratio
- GNSS N/A
- ME N/A
- Revenue Growth
- GNSS N/A
- ME N/A
- 52 Week Low
- GNSS $1.51
- ME $2.66
- 52 Week High
- GNSS $4.04
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- GNSS 38.98
- ME 47.12
- Support Level
- GNSS $2.57
- ME $3.37
- Resistance Level
- GNSS $2.81
- ME $4.18
- Average True Range (ATR)
- GNSS 0.17
- ME 0.26
- MACD
- GNSS 0.04
- ME 0.03
- Stochastic Oscillator
- GNSS 33.33
- ME 37.95
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.